Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches.

Kabashima, Ayano; Shimada, Shu; Shimokawa, Masahiro; Akiyama, Yoshimitsu; Tanabe, Minoru; Tanaka, Shinji

Kabashima, Ayano; Shimada, Shu; Shimokawa, Masahiro; Akiyama, Yoshimitsu; Tanabe, Minoru; Tanaka, Shinji.

Afiliação

Kabashima A; Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Shimada S; Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Shimokawa M; Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Akiyama Y; Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Tanabe M; Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Tanaka S; Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

J Hepatobiliary Pancreat Sci ; 28(1): 62-75, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33259135

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Carcinoma Hepatocelular/genética; Carcinoma Hepatocelular/terapia; Terapia Combinada; Humanos; Imunoterapia; Neoplasias Hepáticas/genética; Neoplasias Hepáticas/terapia; Microambiente Tumoral

Palavras-chave

combination therapy; hepatocellular carcinoma; immunotherapy; molecular targeted therapy; subclass classification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google